Srivastava receives $763,367 in subproject funding

Arun Srivastava, Ph.D., a professor of pediatrics and chief of the pediatrics cellular and molecular therapy division, received $763,367 in subproject funding from the National Institute of Diabetes & Digestive & Kidney Diseases for his research on liver-directed adeno-associated virus gene therapy for correction of genetic and metabolic abnormalities.